Liquid-Filled Capsules: From Niche to Mainstream

Liquid-filled capsules have moved from a niche dosage form to a mainstream option for delivering complex, poorly soluble and sensitive active pharmaceutical ingredients (APIs).¹ Their evolution reflects advances in formulation science, precision filling technologies and a more rigorous regulatory focus on process understanding and control across the finished dosage form life cycle.^2,3 

As a result, liquid-filled capsules are no longer a specialized workaround but a technically sophisticated platform that demands deliberate alignment among formulation design, manufacturing capability and quality strategies.

This article reviews current thinking on the development and manufacture of liquid-filled capsules, with emphasis on enabling technologies, critical unit operations, quality and regulatory expectations, and emerging trends that are likely to shape future practice.

Advantages of Liquid-Filled Capsules

Liquid-filled capsules can be configured as two-piece hard capsules or as one-piece sealed formats and are widely used to deliver oils, solutions, suspensions or semi-solids.¹ They are particularly attractive for improving the bioavailability of poorly water-soluble drugs via lipid-based or other solubilizing systems, and for enabling low-dose or highly potent APIs where precise dosing and containment are essential.^1,4 Compared with conventional powder-filled capsules, liquid-filled systems can offer improved dose uniformity at low strengths and reduced operator exposure to airborne particulates.⁴

From a development standpoint, the format allows formulators to decouple certain challenges in drug product design. Lipid, surfactant or co-solvent systems can be optimized to maintain the API in a solubilized or finely dispersed state, which can simplify downstream processing compared with direct compression or complex granulation schemes.^1,4 At the same time, the capsule shell provides a flexible, modular container–closure solution that can be adapted in size and composition to different patient populations and markets.^1,2

Formulation and Shell Selection

Liquid Fill Design

Designing the liquid fill is central to achieving both performance and manufacturability. Lipid-based systems, self-emulsifying or self-microemulsifying drug delivery systems, and co-solvent blends are frequently employed to enhance solubility and modulate absorption of poorly soluble APIs.^1,4 Key formulation variables include:

• Solvent and lipid selection to balance solubility, chemical stability, and viscosity^1,4
• Use of surfactants and co-solvents to promote dispersion in gastrointestinal fluids without causing capsule shell softening or leakage^1,4
• Inclusion of antioxidants, chelating agents, and oxygen-scavenging strategies to protect oxidation-prone APIs¹

Formulators must also consider rheological properties, as viscosity directly affects pumpability, fill-weight accuracy and the propensity for dripping or smearing during high-speed filling operations.⁵ For semi-solid fills, the fill temperature window and solidification profile are critical to prevent phase separation, sedimentation or crystallization over shelf life.^1,4

Capsule Shell Materials

Choice of capsule shell is another pivotal design decision. Traditional gelatin shells remain widely used but are increasingly complemented or replaced by hydroxypropyl methylcellulose (HPMC) and other cellulose-based or polysaccharide shells.^2,6 Market and patient considerations (dietary restrictions, religious requirements, and “clean label” preferences) are strong drivers for these alternatives, but they also bring technical implications.^2,6

Gelatin offers favorable mechanical properties and well-characterized performance but is sensitive to moisture and temperature and may interact with certain aldehydes or hygroscopic excipients.^2,6 Cellulose-based shells can improve stability in some conditions and reduce reliance on animal-derived sources, but they differ in oxygen and moisture permeability, gelling behavior, and compatibility with specific liquid vehicles.^2,6 Alignment between the liquid fill and shell material, including plasticizer and moisture content, is therefore critical to avoid leakage, brittleness or softening during storage.^1,2

Core Unit Operations in Manufacturing

Although process configurations vary, liquid-filled hard capsule manufacturing typically comprises four major stages: compounding, capsule preparation and liquid filling, sealing or banding, and packaging.^3,5,6 Each stage presents its own technical and control challenges.

Compounding and Bulk Handling

In the compounding step, excipients and APIs are combined under controlled temperature and mixing conditions to ensure homogeneity and to achieve the target viscosity and physical state.^3,4 If the fill is a suspension, maintaining uniform particle distribution and avoiding segregation over hold times becomes a key concern.^3,5 In line with regulatory guidance on finished dosage manufacture, defined and justified hold times, mixing durations and environmental conditions (e.g., humidity, oxygen exposure) are expected, particularly when bulk is held prior to filling.^7,8

Bulk solution or suspension is typically filtered to remove particulates that could interfere with filling nozzles or compromise product quality, and may be handled under inert gas where oxygen-sensitive APIs are involved.^1,4 The design space for bulk handling must minimize temperature excursions that could change viscosity or cause solubility shifts leading to precipitation.^3,4

Capsule Prep and Liquid Filling

Empty hard capsules are oriented, opened and presented to filling nozzles in automated machines that may operate in intermittent or continuous motion.^5,6 High-precision metering systems — such as rotary piston, peristaltic, or time-pressure pumps — are used to deliver defined volumes of liquid into each capsule body.^5,6 The design of the filling system is tailored to fill volume, viscosity and desired accuracy, with modern equipment capable of very tight fill-weight tolerances even at relatively low volumes.⁵

Process robustness at this stage depends on:

• Precise control of liquid temperature to maintain consistent viscosity⁵
• Optimization of nozzle dimensions, stroke, and suck-back to suppress dripping and mitigate wetting of sealing surfaces^5,6
• Synchronization between capsule handling and pump operation to avoid splashing or incomplete filling⁵

Process analytical tools and at-line checks — such as in-process weight monitoring or gravimetric sampling — are widely used to verify fill-weight uniformity and to detect trends before they result in out-of-specification batches.^3,5

Sealing, Banding and Leak Prevention

Liquid-filled two-piece capsules generally require sealing to ensure integrity during handling, storage and transport.^3,5 Banding is a common approach, in which a thin layer of a shell-compatible polymer (e.g., gelatin or HPMC solution) is applied around the capsule joint and then dried to form a continuous seal.^1,3,5 Automated banding systems guide capsules through a controlled application and drying sequence, providing both tamper-evidence and liquid tightness.^1,3,5

Alternative sealing methods include mechanical locking enhancements, spraying or dipping of sealant liquids, and thermal or ultrasonic techniques applied in specialized systems.^3,5 Whatever the method, critical parameters include:

• Sealant viscosity and solids content^3,5
• Application volume and uniformity around the joint³
• Drying temperature, humidity and residence time to avoid shell deformation or over-drying^3,5

Leak testing, often via vacuum or pressure differentials, is employed on a sampling or, in some cases, a 100% basis to verify seal integrity, especially for high-value products.^3,5 Vision systems may also monitor band continuity, capsule dimensions, and cosmetic defects online.^3,6

Final Drying, Inspection and Packaging

After sealing, capsules typically undergo controlled drying to reach the target moisture and mechanical properties.^3,5 Overly aggressive drying can induce brittleness, while insufficient drying may leave shells susceptible to deformation or microbial growth under certain conditions.^2,7 Final polishing and automated visual inspection remove loose particles and identify defects such as dents, leaks, or misaligned caps.^3,6

Packaging defines the product’s protection strategy. Blister packs with barrier films, bottles with desiccants, and nitrogen-flushed containers are common options for oxidation- or moisture-sensitive products.^1,2 Regulatory expectations emphasize demonstration that the selected container-closure system maintains product quality over the labeled shelf life, including after typical in-market temperature and humidity excursions.^7,8

Quality and Regulatory Expectations 

While there is no dosage-form-specific international guideline covering only liquid-filled capsules, broader expectations for finished dosage form manufacture and quality are clearly articulated in regional guidance and ICH principles.^7,9 Regulators expect a comprehensive, coherent description of the manufacturing process, including critical steps, control strategies, and how each element contributes to assuring the quality attributes of the finished product.^7,8

Process Understanding and Control

In line with quality by design concepts, applicants are encouraged to identify and justify critical process parameters (CPPs) and critical quality attributes (CQAs), and — where appropriate — to define a design space for operations such as compounding, filling and sealing.^7,8 For liquid-filled capsules, relevant CPPs often include:

• Mixing time, shear and temperature profiles during compounding^3,4
• Fill temperature, pump stroke and speed settings for the filling operation^5,6
• Banding solution characteristics and drying conditions^3,5

Hold times at each stage, especially for bulk liquid and partially processed intermediates, should be justified with supporting stability data.^7,8 Guidance on finished dosage manufacture emphasizes that prolonged storage periods must be scientifically justified and consistent with good manufacturing practice, including demonstration that CQAs remain within specification over these intervals.⁷

Content Uniformity and Performance Testing

Because liquid fills may contain solubilized or suspended APIs, dose uniformity is critical.^3,4 Regulatory expectations include validated assays for content uniformity, supported by robust in-process controls on fill-weight and mixing.^3,8 For suspension fills, attention is given to sedimentation and resuspendability during the filling campaign and across any bulk hold time.^3,4

Performance testing must be appropriate to the formulation. For immediate-release products, dissolution or dispersion testing is typically required to demonstrate that the fill disperses and releases the API at an acceptable rate.⁸ For modified-release or enteric-coated capsule presentations, additional testing regimes — such as pH-shift dissolution — are applied to verify targeted release profiles.⁸

Shell-Fill and Packaging Interactions

Regulators also scrutinize interactions between the liquid fill and capsule shell or packaging, as these can impact integrity, stability and patient safety.^1,2 Potential issues include migration of plasticizers, shell deformation from aggressive solvents or surfactants, and changes in mechanical properties under high humidity or temperature.^1,2 For cellulose-based shells, differences in water uptake and gas permeability compared with gelatin require specific evaluation.^2,6

Container-closure system suitability must be demonstrated through stability studies under long-term, intermediate and accelerated conditions, showing that the product remains within specifications for potency, degradation products, appearance and physical properties.^7,8 Any use of high-barrier materials or active packaging (e.g., desiccants) should be justified based on product sensitivity.^1,2

Current Technology and Materials Trends

Precision Filling and Integrated Inspection

Recent years have seen growing adoption of more advanced filling technologies and integrated inspection systems for liquid-filled capsules.^1,3,5 New machine designs can handle a wider range of viscosities and fill volumes while maintaining high accuracy and throughput.^5,9 Temperature-controlled product lines, servo-driven pumps, and more sophisticated nozzle designs enable smooth dosing of both low- and high-viscosity fills.^5,9

At the same time, automated inspection using high-speed cameras and image analysis software is becoming more prevalent to support 100% inspection strategies for integrity and cosmetic quality.^3,6 Inline or at-line weighing systems, combined with statistical process control, help manufacturers detect drift in fill weights or seal quality in near real time.^3,5 This data-rich environment aligns with regulatory interest in continuous process verification and ongoing process monitoring.^7,8

Polymer Innovation and Capsule Functionality

Advances in polymer science are reshaping capsule shell design, driving a shift toward cellulose-based and other alternative materials for supply security and patient preference.^2,6 These materials allow tuning of disintegration behavior and barrier properties, enabling more sophisticated control of release profiles and stability for liquid fills.^2,6

Interest is growing in shells that deliver delayed or targeted release without added coatings, and in designs optimized for compatibility with specific solvents or surfactants.^2,6 These advances are particularly important as more complex APIs — such as highly lipophilic compounds and sensitive biologics — move into liquid-filled formats.^1,4

Toward Smarter, More Flexible Manufacturing

Several converging trends suggest how liquid-filled capsule manufacturing may evolve over the coming decade. First, the integration of continuous or semi-continuous processing concepts, already gaining traction in other solid oral dosage forms, is likely to expand in this space.⁹ Continuous compounding and feeding of liquid fill, coupled with synchronized filling and sealing operations, could reduce hold times, improve material traceability, and enable more agile responses to demand.⁹ Achieving this will require robust control strategies, including real-time monitoring of viscosity, temperature and fill-weight, and sophisticated data analytics to support rapid decision-making.^7,9

Second, demand for flexible, modular equipment platforms is expected to grow, allowing seamless scaling from development to clinical to commercial manufacturing on equipment families that share core design principles.^5,9 Such platforms can reduce tech-transfer complexity and facilitate life cycle management changes, as process knowledge gathered at small scale is more directly applicable at higher throughputs.^5,9

Third, continued innovation in capsule shell materials and barrier films will likely open new possibilities for formulating particularly sensitive APIs and for tailoring release profiles without resorting to complex multi-step coating processes.^2,6 This may include shells optimized for oxygen-sensitive or moisture-sensitive liquid fills, as well as specialized designs for multi-particulate or combined liquid-solid fills.^1,2

Finally, regulatory expectations will continue to emphasize systematic process understanding and data-driven control strategies.^7,9 Sponsors that can demonstrate strong linkages between material attributes, process parameters and product performance — supported by risk-based control strategies — are well positioned to gain flexibility in post-approval changes and capitalize on emerging technologies.^7,8 For liquid-filled capsules, this means integrating formulation science, advanced equipment capabilities, and robust quality systems into a coherent, life cycle-oriented manufacturing strategy.

References

1. Liquid-Filled Hard Capsules Market to Reach US$2.7Bn by 2033. (2026, Jan). Persistence Market Research.
2. Liquid Filled Hard Capsule Market Size, Share, Analysis, 2025–2032. (2026, Feb). Fortune Business Insights. 
3. Liquid Filled Hard Capsules Market Size, Trends, Share, Forecasts. (2025, May). Spherical Insights.
4. Liquid Capsule Manufacturing: What to Know. (2022, April). Ascendia Pharma Solutions. 
5. Liquid Capsule Filling Machine: The Ultimate FAQ Guide. SaintyCo. [accessed Feb 2026]  
6. Langhauser, K. (2025, Feb). 2025 Predictions: Industry Leaders Weigh in on the Future of Oral Dosage Forms. Tablets & Capsules.
7. Guideline on manufacture of the finished dosage form. (2017, July). European Medicines Agency.
8. Manufacture of the finished dosage form (human)-Scientific guideline. European Medicines Agency. [accessed Feb 2026]
9. Brown, E. (2025, Sept). Why Liquid-Filled Capsules Are Shaping the Future of Oral Dosage Forms. Coherent Market Insights.